Rapid Micro Biosystems Inc Cl A (RPID)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -47,123 | -46,889 | -52,467 | -60,806 | -73,524 |
| Depreciation Amortization | 3,252 | 3,362 | 3,105 | 2,837 | 1,529 |
| Accounts receivable | 4,387 | -1,987 | -163 | -364 | -17 |
| Accounts payable and accrued liabilities | 1,600 | 562 | -3,455 | 1,484 | -524 |
| Other Working Capital | 6,064 | -4,771 | 555 | -5,325 | -7,998 |
| Other Operating Activity | 758 | 5,570 | 7,344 | 3,627 | 25,570 |
| Operating Cash Flow | $-31,062 | $-44,153 | $-45,081 | $-58,547 | $-54,964 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -850 | -1,365 | -1,845 | -6,740 | -3,197 |
| Purchase Of Investment | -27,076 | -35,035 | -62,492 | -179,229 | -25,092 |
| Sale Of Investment | 42,255 | 73,057 | 106,490 | 92,500 | 15,000 |
| Investing Cash Flow | $14,329 | $36,657 | $42,153 | $-93,469 | $-13,289 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 20,000 | 0 | N/A | N/A | N/A |
| Debt Repayment | -30 | -35 | -37 | -33 | -26,171 |
| Common Stock Issued | 1,098 | 238 | 186 | 726 | 165,039 |
| Other Financing Activity | -1,297 | 0 | 0 | 0 | 77,877 |
| Financing Cash Flow | $19,771 | $203 | $149 | $693 | $216,745 |
| Beginning Cash Position | 17,276 | 24,569 | 27,348 | 178,671 | 30,179 |
| End Cash Position | 20,314 | 17,276 | 24,569 | 27,348 | 178,671 |
| Net Cash Flow | $3,038 | $-7,293 | $-2,779 | $-151,323 | $148,492 |
| Free Cash Flow | |||||
| Operating Cash Flow | -31,062 | -44,153 | -45,081 | -58,547 | -54,964 |
| Capital Expenditure | -850 | -1,365 | -1,845 | -6,740 | -3,217 |
| Free Cash Flow | -31,912 | -45,518 | -46,926 | -65,287 | -58,181 |